A heart murmur is not a disease you fix directly. It is a sound, produced by blood flowing turbulently through or near the heart, and what you actually treat is whatever is causing that turbulence. In many cases, nothing needs to be done at all, because the murmur is harmless. When it does signal a structural problem, treatment ranges from monitoring and medication to catheter-based procedures and open-heart surgery, depending on the valve or defect involved and how much it affects heart function.
Not Every Murmur Needs Treatment
Roughly half of all children and a meaningful fraction of adults have heart murmurs that are completely innocent. These are sometimes called “functional” or “flow” murmurs, and they arise from normal blood flow moving through a healthy heart. In children, the most common type is the vibratory Still’s murmur, a musical-sounding hum heard best in the middle of the chest. One study evaluating diagnostic methods in pediatric murmurs found that classic vibratory Still’s murmurs accounted for over half of all innocent murmurs detected.1PubMed Central. Evaluation of Diagnostic Methods in the Differentiation of Heart Murmurs in Children These sounds tend to be soft, change with body position, and disappear as a child grows. An innocent murmur requires no treatment, no activity restrictions, and no follow-up beyond what your doctor considers routine.
In adults, innocent murmurs are less common but still occur, particularly during states of high blood flow such as exercise, fever, or pregnancy. The distinction between innocent and pathological murmurs matters enormously, because it determines whether the path forward is reassurance or a full cardiac workup.
What Causes a Murmur That Does Need Attention
Pathological murmurs come from structural problems in or around the heart. The sound itself is generated when blood encounters turbulence. Research using sensors placed directly inside arteries has shown a tight relationship between turbulent energy and the loudness of murmurs heard through a stethoscope: louder murmurs consistently corresponded to more powerful turbulence.2PubMed. Turbulent blood flow in humans: its primary role in the production of ejection murmurs That turbulence can be created by several underlying problems.
Valve disease is the most frequent culprit. In developed countries, calcific aortic stenosis, a condition in which calcium deposits gradually stiffen and narrow the aortic valve, is the most prevalent valve disorder.3PubMed Central. Calcific aortic stenosis Mitral regurgitation, where the mitral valve fails to close tightly and allows blood to leak backward, is another common source. These conditions produce characteristic murmur patterns that experienced clinicians can often distinguish by ear.
Congenital heart defects are another major category. Holes between heart chambers, such as ventricular septal defects (VSDs) and atrial septal defects (ASDs), create abnormal flow paths that generate audible turbulence. These are among the most common birth defects worldwide and are frequently the reason a pediatrician first detects a murmur in infancy or early childhood.
When the Cause Is Not the Heart Itself
Some murmurs arise not from a structural heart problem but from conditions elsewhere in the body that change blood flow dynamics. Severe anemia typically produces a loud murmur heard at the chest because the heart compensates for reduced oxygen-carrying capacity by pumping more forcefully and quickly. Pregnancy increases blood volume and cardiac output, which can generate an audible flow murmur in women with perfectly normal hearts. Hyperthyroidism speeds up the heart and increases circulation, producing a similar effect.4CHEST. Mechanisms of the Heart Murmur
These murmurs disappear when the underlying condition is treated. Correcting the anemia with iron supplementation or a blood transfusion, delivering the baby, or bringing thyroid hormone levels under control resolves the extra turbulence. No cardiac procedure is necessary. This is one reason a thorough evaluation matters: a murmur that sounds alarming through a stethoscope might be pointing away from the heart entirely.
How Doctors Diagnose What Is Behind the Sound
The stethoscope remains the first tool used to evaluate a murmur. The technique has been in use since René Laënnec invented the stethoscope in 1816, and while the instrument has evolved, the skill of listening and interpreting sounds is still foundational to cardiology.5PubMed Central. The first 200 years of cardiac auscultation and future perspectives A skilled clinician notes the timing (systolic versus diastolic), location, pitch, and intensity of the murmur. These characteristics narrow the differential diagnosis before any imaging is ordered.
When a murmur raises concern, echocardiography is the standard next step. A transthoracic echocardiogram (TTE), performed by pressing an ultrasound probe against the chest wall, provides real-time images of valve motion, chamber size, and blood flow direction. For cases where TTE does not give a clear enough picture, a transesophageal echocardiogram (TEE), which places a small probe in the esophagus directly behind the heart, can reveal structures that are hard to see from the chest surface.
Cardiac MRI has become an increasingly useful alternative when echocardiography leaves questions unanswered. CMR provides detailed images of valve anatomy and allows precise measurement of how much blood is leaking through a faulty valve or how severely a narrowed valve is obstructing flow.6PubMed Central. Cardiovascular magnetic resonance in the evaluation of heart valve disease It is particularly helpful when echocardiographic windows are limited by body habitus or lung disease.
An emerging layer of technology involves artificial intelligence applied to stethoscope recordings. A deep learning algorithm tested on a large clinical database detected murmurs with sensitivity and specificity comparable to expert cardiologists, and when the analysis was restricted to louder murmurs, sensitivity rose to about 90%.7PubMed Central. Deep Learning Algorithm for Automated Cardiac Murmur Detection via a Digital Stethoscope Platform A separate study found that AI-augmented digital stethoscopes had significantly higher sensitivity for detecting moderate-to-severe valve disease than standard clinical auscultation, catching twice as many previously undiagnosed cases.8PubMed Central. Artificial-intelligence-enabled digital stethoscope improves point-of-care screening for moderate-to-severe valvular heart disease These tools are not replacing cardiologists, but they could be valuable in primary care settings where a busy doctor may not catch a subtle murmur during a brief office visit.
Murmurs That Resolve on Their Own
Some structural heart defects heal without intervention. This is especially true for ventricular septal defects in children. In a long-term follow-up of 187 patients with VSDs, spontaneous closure or marked reduction in defect size occurred in about one in five cases, and in the majority of those, the defect appeared to have closed completely, judged by the disappearance of the murmur and its associated findings.9Circulation. Spontaneous closure of ventricular septal defects The phenomenon is most likely when the defect is small and the child has no symptoms of heart failure or poor growth.
This means that for a baby or toddler diagnosed with a small VSD and a loud murmur but normal heart function, the standard approach is watchful waiting with periodic echocardiograms rather than rushing toward surgery. If the murmur fades and imaging confirms the hole has closed, no further treatment is needed.
Catheter-Based Procedures
When a murmur is caused by a valve or structural defect that needs fixing, the least invasive option is often a catheter-based (transcatheter) procedure. These involve threading a thin tube through a blood vessel, usually in the groin, up to the heart, and deploying a device or replacement valve without opening the chest.
Transcatheter Aortic Valve Replacement
For severe aortic stenosis, TAVR has become one of the most transformative cardiac procedures of the past two decades. A recent systematic review and meta-analysis comparing TAVR to traditional open-heart surgical aortic valve replacement (SAVR) found that TAVR reduced all-cause mortality by about 28%, cardiovascular mortality by 37%, and major bleeding by 56%. Hospital stays were shorter by roughly three and a half days. However, TAVR was associated with a higher rate of permanent pacemaker implantation, and stroke rates were similar between the two approaches.10European Heart Journal. Comparative outcomes of transcatheter aortic valve replacement versus surgical aortic valve replacement in severe aortic stenosis: a systematic review and meta-analysis
TAVR was originally reserved for patients too frail or sick for open surgery. Data from the large PARTNER trial showed that about a third of patients experienced a poor outcome at six months, with predictive models identifying pre-existing frailty and certain comorbidities as major risk factors.11PubMed Central. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER trial Over time, TAVR has expanded to lower-risk patients, and it is now widely used across the spectrum of surgical risk.
For patients who already have a surgical bioprosthetic valve that has worn out, a valve-in-valve TAVR can place a new transcatheter valve inside the old one. In a multi-center study of 116 patients who received this approach, average valve function remained stable for up to five years, and clinically significant structural deterioration of the new valve was uncommon.12PubMed. Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement
MitraClip for Mitral Regurgitation
When the mitral valve leaks significantly, one catheter-based option is the MitraClip, a small device that clips the two leaflets of the mitral valve together at their midpoint to reduce backflow. A systematic review covering nearly 3,000 patients found that the procedure had a high acute success rate of about 91%, with very low procedural mortality. At follow-up averaging around 310 days, the proportion of patients with severe mitral regurgitation dropped dramatically, and most patients experienced meaningful improvement in symptoms and functional class.13PubMed. Safety and efficacy of the MitraClip system for severe mitral regurgitation: a systematic review
The trade-off is that MitraClip does not eliminate regurgitation as completely as surgical repair. A meta-analysis comparing MitraClip to surgery found that the rate of significant residual leakage was substantially higher in the MitraClip group.14PubMed Central. A meta-analysis of MitraClip system versus surgery for treatment of severe mitral regurgitation At one year, however, most surviving MitraClip patients maintained good results, with roughly 85% still having only mild-to-moderate regurgitation and similar percentages reporting functional improvement.15PubMed. One-Year Outcomes After MitraClip for Functional Mitral Regurgitation For patients who are poor surgical candidates due to age or other illnesses, MitraClip offers a real alternative where there previously was none.
Device Closure of Septal Defects
For holes between the heart’s chambers, percutaneous device closure has become the preferred approach for the majority of secundum-type ASDs. A device resembling a small double umbrella is guided through a catheter, positioned across the hole, and deployed to seal it. Multiple studies have shown lower complication rates, shorter hospital stays, and lower mortality compared to surgical repair.16PubMed. Update on Transcatheter Device Closure of Congenital Septal Defects Device closure is also an accepted alternative for some types of VSDs, though challenges remain for certain anatomic configurations, particularly perimembranous defects near the heart’s conduction system.17PubMed. Transcatheter Closure of Atrial and Ventricular Septal Defects: JACC Focus Seminar
In select cases where a patient has both a VSD and an ASD, combined device closure in a single session guided by echocardiographic imaging has been performed safely, avoiding the need for two separate procedures or open-heart surgery.18PubMed Central. One-Stop Device Closure for Ventricular Septal Defect with Atrial Septal Defect Guided by Transesophageal Echocardiography
Surgical Valve Repair and Replacement
When catheter-based approaches are not suitable, open-heart surgery remains the definitive treatment for severe valve disease. For mitral regurgitation, surgeons often try to repair the native valve by reshaping the leaflets and reinforcing the valve ring with an annuloplasty band. Valve repair preserves the patient’s own tissue and generally produces better long-term outcomes than replacement when it is technically feasible.
When repair is not possible, the valve is replaced entirely with either a mechanical or a biological (tissue) prosthesis. The choice between them involves a genuine trade-off. A 20-year comparative study found that mechanical valves carry an increased risk of hemorrhage due to the lifelong blood-thinning medication required to prevent clots on the artificial surface, while tissue valves carry an increasing risk of reoperation over time because they gradually wear out.19PubMed. Twenty-year comparison of tissue and mechanical valve replacement
In practice, the decision often comes down to age and lifestyle. Younger patients may lean toward mechanical valves to avoid a second surgery in their fifties or sixties, accepting the need for daily blood thinners and regular blood tests. Older patients often choose tissue valves because the prosthesis is likely to last the rest of their lives, and they avoid the bleeding risk and monitoring burden of anticoagulation. There is no universally “right” choice; it is one of the more genuinely individual decisions in cardiac care.
Recovery and Cardiac Rehabilitation
After any valve surgery, recovery involves more than waiting for the incision to heal. Cardiac rehabilitation programs that combine supervised exercise, education, and psychological support have been shown to increase exercise capacity and quality of life and help patients return to work, with minimal risk of serious adverse effects.20PubMed. Cardiac rehabilitation after heart valve surgery
Starting rehabilitation early appears to matter. A randomized trial found that patients who began a structured rehab program while still in the hospital after valve surgery showed significant improvement in physical function at discharge, and the benefit persisted at six months of follow-up compared to patients who received usual care alone.21PubMed Central. Effectiveness of early cardiac rehabilitation in patients with heart valve surgery: a randomized, controlled trial A separate randomized trial confirmed that cardiac rehab increased peak oxygen consumption, a key measure of aerobic fitness, at four months. However, the same trial found no improvement in mental health scores, which is worth keeping in mind: physical recovery and emotional adjustment after heart surgery do not always move in lockstep.22Heart. Cardiac rehabilitation increases physical capacity but not mental health after heart valve surgery: a randomised clinical trial
Antibiotic Prophylaxis and Dental Work
One question that comes up after any heart valve repair or replacement is whether you need antibiotics before dental visits. The concern is infective endocarditis, a serious infection of the heart’s inner lining or valves that can be seeded by bacteria entering the bloodstream during dental procedures. The American Heart Association updated its guidelines on this topic and significantly narrowed the list of people who need prophylactic antibiotics. Prophylaxis is now recommended only for patients with conditions that carry the highest risk of bad outcomes from endocarditis, such as prosthetic heart valves, a history of prior endocarditis, certain congenital heart defects, and cardiac transplant recipients who develop valve problems.23PubMed. Prevention of infective endocarditis: guidelines from the American Heart Association
The rationale for restricting prophylaxis was that only an extremely small number of endocarditis cases could plausibly be prevented by antibiotics before dental work, even assuming 100% effectiveness. Meanwhile, antibiotic overuse drives resistance and carries its own risks. Guidelines in several countries have been shortened considerably over the years for exactly this reason.24PubMed Central. Antibiotic Prophylaxis Prior to Dental Procedures If you have a repaired or replaced valve, ask your cardiologist whether you fall into the high-risk group. Many people with murmurs, even those who have had procedures, do not need to take antibiotics before a cleaning.
Disparities in Who Gets Treated
Access to advanced heart murmur treatments is not evenly distributed. Research into TAVR utilization across major U.S. metropolitan areas has found that procedure rates are significantly lower in zip codes with lower household incomes, higher proportions of residents dually eligible for Medicaid, and higher community distress scores. Even after adjusting for age and clinical comorbidities, rates of TAVR were lower in areas with higher proportions of Black and Hispanic residents.25PubMed Central. Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas A separate population-level analysis of national inpatient data confirmed that the likelihood of receiving either TAVR or surgical valve replacement decreased with lower neighborhood income.26Scientific Reports. Socioeconomic disparity in transcatheter and surgical aortic valve replacement: a population study of National Inpatient Sample from 2015 to 2020
These disparities matter because aortic stenosis is progressive. A murmur that starts as mild obstruction will worsen over years, and once symptoms develop, survival without intervention drops sharply. If the patients who most need the procedure are the least likely to receive it due to geography, income, or race, the consequences are measured in lives. AI-augmented screening tools deployed in underserved primary care settings could eventually help identify valve disease earlier in these populations, but the larger barriers involve insurance coverage, proximity to high-volume centers, and referral patterns that still skew toward wealthier, whiter communities.